ClinicalTrials.Veeva

Menu

Myocardial Work and Metabolism in CRT (WORK-CRT)

U

Universitaire Ziekenhuizen KU Leuven

Status

Unknown

Conditions

Cardiomyopathy
Left Bundle Branch Block
Left Ventricular Dyssynchrony
Heart Failure

Treatments

Device: Cardiac resynchronisation therapy
Other: Positron Emission Tomography
Other: Magnetic Resonance Imaging
Other: Echocardiography

Study type

Interventional

Funder types

Other

Identifiers

NCT02537782
S538235_v1.2

Details and patient eligibility

About

Several attempts have been made to refine selection criteria for cardiac resynchronisation therapy (CRT) in heart failure patients with reduced ejection fraction (HFrEF). Previously proposed parameters probably do not sufficiently reflect the underlying mechanical dyssynchrony of the left ventricle (LV). Earlier work of our research group suggests that better candidate selection can rely on the direct observation or measurement of this LV mechanical dyssynchrony by means of non-invasive imaging. In this study apical rocking and other non-invasive measures of LV mechanical dyssynchrony will be applied to evaluate regional myocardial workload and metabolism, and determine their predictive value in CRT response.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

Subject is eligible for CRT implantation according to current European Society of Cardiology guidelines of 2013.

  • The patient should receive guideline-directed optimal medical therapy for heart failure and left ventricular (LV) function must be severely depressed (LV ejection fraction ≤35%).
  • The patients should be in NYHA functional class II, III or ambulatory IV.
  • The patient should present a left bundle branch block (LBBB) with QRS duration of >120ms or a non-LBBB with QRS >150ms.
  • Also patients with conventional pacemaker in NYHA functional class III and ambulatory IV if high percentage of ventricular pacing, are eligible for CRT implantation.
  • Subject is in stable sinus rhythm at the time of CRT implant and during the last 2 weeks prior to inclusion.
  • Subject is 18 years or older and able and willing to consent.

Exclusion Criteria:

  • Impossible to obtain LV volumes by echocardiography.
  • Right bundle branch block.
  • Permanent atrial fibrillation, flutter or tachycardia (>100 bpm).
  • Recent myocardial infarction, within 40 days prior to enrolment.
  • Subject underwent coronary artery bypass graft (CABG) or valve surgery, within 90 days.
  • Post heart transplantation, or is actively listed on the transplantation list, or has reasonable probability (per investigator's discretion) of undergoing transplantation in the next year.
  • Implanted with a LV assist device (LVAD), or has reasonable probability (per investigator's discretion) of receiving a LVAD in the next year.
  • Severe aortic stenosis (with a valve area of <1.0 cm2 or significant valve disease expected to be operated on within study period).
  • Complex and uncorrected congenital heart disease.
  • Breastfeeding women, women of child bearing potential.
  • Enrolled in one or more concurrent studies that would confound the results of this study.

Trial design

200 participants in 1 patient group

Cardiac resynchronisation therapy implantation
Other group
Description:
Patients with current guideline-based indication for CRT implantation.
Treatment:
Other: Echocardiography
Other: Magnetic Resonance Imaging
Device: Cardiac resynchronisation therapy
Other: Positron Emission Tomography

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems